Jupiter Neurosciences News

Latest Jupiter Neurosciences Stock News & JUNS Headlines

Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson's Disease and Exploration of Strategic Options to Maximize Shareholder Value

a month ago | globenewswire.com

Jupiter Neurosciences announces pricing of $2M registered direct offering

3 months ago | https://thefly.com

Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering

3 months ago | globenewswire.com

Jupiter Neurosciences Stock Surges Friday: What's Driving the Action?

3 months ago | benzinga.com

Jupiter Neurosciences, Inc. Announces Reverse Stock Split

3 months ago | globenewswire.com

Jupiter Neurosciences, Inc. Announces Reverse Stock Split

3 months ago | globenewswire.com

Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

4 months ago | globenewswire.com

Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

4 months ago | globenewswire.com

Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson

4 months ago | globenewswire.com

Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson's Disease

6 months ago | globenewswire.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

JUNS

Jupiter Neurosciences

$ 1.76

-5.38%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 2 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Jupiter Neurosciences News

Latest Jupiter Neurosciences Stock News & JUNS Headlines

Download App

People Also Watch

Explore our Tools